VAXXILON AG has a total of 13 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are YABAO PHARMACEUTICAL GROUP CO LTD, INST INT PATHOLOGIE CELLULAIRE and BONTAC BIO ENGINEERING SHENZHEN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Sugars | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Pereira Claney Lebev | 13 |
#2 | Monnanda Bopanna | 11 |
#3 | Von Bonin Arne | 11 |
#4 | Lisboa Marilda P | 6 |
#5 | Knopp Daniel | 6 |
#6 | Przygodda Jessica | 5 |
#7 | Oestreich Sylvia | 5 |
#8 | Parameswarappa Sharavathi Guddehalli | 5 |
#9 | Naini Arun | 5 |
#10 | Emmadi Madhu | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020104697A1 | Stable vaccine against clostridium difficile | |
EP3492481A1 | Vaccine against klebsiella pneumoniae | |
EP3492482A1 | Vaccine against klebsiella pneumoniae |